Dr. Po N. Lam Performs Leading-Edge Robotic Surgery with Associated Medical Professionals of NY, an Affiliate of U.S. Urology Partners

2023-04-25
SYRACUSE, N.Y.--(BUSINESS WIRE)--Dr. Po N. Lam, a nationally recognized urologist and robotic surgeon with Associated Medical Professionals of NY (A.M.P.), is working to provide residents of Syracuse and the surrounding Central New York region access to the next generation of robotic surgery.
'Patients are also able to leave the hospital sooner and recover faster in the comfort of their homes'
The introduction of robotically assisted surgery revolutionized the ability of physicians to perform minimally invasive surgical procedures, replacing the use of open surgery that requires a large incision with multiple small access points. Long-handled tools and a camera controlled remotely by the physician are inserted through these access points to perform the medical procedure.
Dr. Lam is the only surgeon in the area who has been specially trained in the technique to use the innovative da Vinci SP (Single Port) system for prostatectomy and other urological procedures. The new SP system only requires one small incision compared to previous robotic surgeries that require 4 to 7 incisions. The system includes multi-jointed, flexible instruments and fully wristed 3D camera. The instruments and the camera emerge through a single access hole and provide 360 degrees of anatomical access.
“Through my work with the new da Vinci SP, I’ve seen numerous benefits with this leading-edge technology that is now available to patients close to home in Central New York. This technology gives the surgeon much more freedom of movement and ability to see the anatomy compared to the old system,” said Po N. Lam, M.D., of Associated Medical Professionals of NY.
“One of the major advantages of the single port surgical technique is reducing the amount of pain during and after robotic surgery. This helps reduce the need for narcotics, which in turn greatly reduces the abuse and potential addiction to narcotics,” Dr. Lam explains.
“Patients are also able to leave the hospital sooner and recover faster in the comfort of their homes,” Dr. Lam continued. “With the strain on staffing at all levels, this is helpful to the patient as well as the hospital. Single port with less incisions offers many benefits to the patient, and I’m pleased to bring those advantages to the Central New York region.”
Other potential benefits of robotic surgery for patients include lower risk of infection or complications, less blood loss, less scarring and faster return to normal activities.
Dr. Lam has performed thousands of robotic procedures in Central New York in the past 16 years. He is certified in da Vinci robotic surgery and serves as a proctor for Intuitive Surgical, Inc. Dr. Lam specializes in advanced robotic surgery in the areas of prostate cancer, kidney cancer, bladder cancer and difficult kidney stones. Dr. Lam is one of the top performing robotic surgeons in the Central New York region.
A podcast of Dr. Lam discussing the robotic surgery he performed at Crouse Health is available here.
About U.S. Urology Partners
U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical and robotic procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners clinical network consists of more than 50 locations throughout the East Coast and Midwest, including Associated Medical Professionals of NY, Central Ohio Urology Group, Florida Urology Center and Urology of Indiana. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。